Company Analysis
Sign in

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Biological Products, (No Diagnostic Substances) · Boston, MA · filing with the SEC since 2020
Full chart Alerts Compare
Grade4.5
◀ Past 4.1● Present 5.1▶ Future 4.2
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

34 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Ginkgo Bioworks Holdings, Inc.’s names, not what it holds today.

Patents granted
34
34 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 8 in 2024 and 5 in 2023
Applications published
75
9 of them in 2025
Names they are printed under
2
a subsidiary
By yearGrantedApplications published
'12'13'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology24
Pharmaceuticals1
Organic fine chemistry1
Basic materials chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Ginkgo Bioworks, Inc. a subsidiary
US, as the owner printed on each patent
34 granted
42 published
Ginkgo Bioworks, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
33 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Mar 4, 202512,239,137Compositions and methods for controlling plant pests and improving plant healthBasic materials chemistryGinkgo Bioworks, Inc.
Feb 25, 202512,234,464Biosynthesis of mogrosidesBiotechnologyGinkgo Bioworks, Inc.
Oct 15, 202412,116,384Virus vectors for targeting ophthalmic tissuesBiotechnologyGinkgo Bioworks, Inc.
Sep 17, 202412,091,435Antibody-evading virus vectorsBiotechnologyGinkgo Bioworks, Inc.
Sep 3, 202412,077,799Chimeric terpene synthasesOrganic fine chemistryGinkgo Bioworks, Inc.
Aug 13, 202412,060,390Antibody-evading virus vectorsBiotechnologyGinkgo Bioworks, Inc.
May 14, 202411,981,914Recombinant adeno-associated virus vectorsBiotechnologyGinkgo Bioworks, Inc.
May 7, 202411,976,096Antibody-evading virus vectorsPharmaceuticalsGinkgo Bioworks, Inc.
Feb 20, 202411,905,523Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-CBiotechnologyGinkgo Bioworks, Inc.
Jan 2, 202411,859,189Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereofBiotechnologyGinkgo Bioworks, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 13, 20252025/0347709SCALABLE, MOBILE, AND RECONFIGURABLE MODULES FOR PROCESSING BIOLOGICAL AND CHEMICAL MATERIALSMeasurementGinkgo Bioworks, Inc.
Oct 23, 20252025/0327058ENGINEERED PHENYLALANINE AMMONIA LYASE AND TYROSINE AMMONIA LYASE ENZYMES FOR PRODUCING AROMATIC COMPOUNDSBiotechnologyGinkgo Bioworks, Inc.
Sep 11, 20252025/0283122BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORSBiotechnologyGinkgo Bioworks, Inc.
Jun 26, 20252025/0207142BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORSBiotechnologyGinkgo Bioworks, Inc.
Jun 5, 20252025/0176558COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS AND IMPROVING PLANT HEALTHBasic materials chemistryGinkgo Bioworks, Inc.
May 8, 20252025/0144245GENE THERAPY FOR ARRHYTHMOGENIC CARDIOMYOPATHYPharmaceuticalsGinkgo Bioworks, Inc.
Mar 20, 20252025/0092095ANTIBODY-EVADING VIRUS VECTORSBiotechnologyGinkgo Bioworks, Inc.
Mar 6, 20252025/0075243BIOSYNTHESIS OF OXYGENATED HYDROCARBONSBiotechnologyGinkgo Bioworks, Inc.
Jan 23, 20252025/0027070ENGINEERED SESQUITERPENE SYNTHASESBiotechnologyGinkgo Bioworks, Inc.
Dec 26, 20242024/0425841ENGINEERED PHENYLALANINE AMMONIA LYASE ENZYMESBiotechnologyGinkgo Bioworks, Inc.
What it applied for, 2024 to 2025: Biotechnology 25 · Pharmaceuticals 2 · Basic materials chemistry 1 · Measurement 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton DNA · research, not advice